2001 - (16)

Schett G, Hayer S, Tohidast-Akrad M, Schmid BJ, Lang S, Turk B, Kainberger F, Haralambous S, Kollias G, Newby AC, Xu Q, Steiner G, Smolen J. 2001. Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic mice. Arthritis Rheum. 2001 Dec;44(12):2888-98. PubMed

Luftig M. A., Cahir-McFarland E., Mosialos G., Kieff E. D., 2001, "Effects of the NIK aly mutation on NF-{kappa}B activation by the Epstein-Barr virus latent infection membrane protein, LT{beta}R, and CD40", J. Biol. Chem., 276, 14602-14606 . PubMed

Kassiotis G., Kollias G., 2001, "Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination", J. Exp. Med., 193, 427-434 . PubMed

Ishii T., Kwon H., Hiscott J., Mosialos G., Koromilas A. E., 2001, "Activation of the IkappaBalpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR", Oncogene, 20, 1900-1912 . PubMed

Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H.-D., Holtmann H., Kollias G., Gaestel M., 2001, "MK2 targets AU-rich elements and regulates biosynthesis of Tumor Necrosis Factor and Interleukin-6 independently at different post-transcriptional levels", J. Biol. Chem., 277, 3065-3068 . PubMed

Mosialos G., 2001,  "Cytokine signaling and Epstein-Barr virus-mediated cell transformation", Cytokine Growth Factor Rev., 12, 259-270 . PubMed

Kassiotis G., Kranidioti K., Kollias G., 2001, "Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness",  J. Neuroimmunol., 119, 239-47 . PubMed

Kontoyiannis D., Kotlyarov A., Carballo E., Alexopoulou L., Blackshear P. J., Gaestel M., Davis R., Flavell R., Kollias G., 2001, "Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology", EMBO J., 20, 3760-3770 . PubMed

Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meodolesi J., Volterra A., 2001, "CXCR4-activated astrocyte glytamate release via TNFα: amplification by microglia triggers neurotoxicity", Nat. Neurosci., 4, 702-10 . PubMed

Kassiotis G., Kollias G., 2001, "TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models", J. Clin. Invest., 107, 1507-8 . PubMed

Panayotou G., Ladbury J., 2001, "Analysis of SH2 domain - phosphopeptide interactions by Isothermal Titration Calorimetry and Surface Plasmon Resonance", Methods Mol. Biol., 124, 295-311. PubMed

Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE. 2001 "Complement activation in factor D-deficient mice". Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14577-82. Epub 2001 Nov 27. PubMed

Volanakis JE. 2001 "Human C-reactive protein: expression, structure, and function". Mol Immunol. 2001 Aug;38(2-3):189-97. Review. PubMed

Xu Y, Narayana SV, Volanakis JE. 2001 "Structural biology of the alternative pathway convertase". Immunol Rev. 2001 Apr;180:123-35. Review. PubMed

Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE. 2001 "Topology and structure of the C1q-binding site on C-reactive protein". J Immunol. 2001 Mar 15;166(6):3998-4004. PubMed

Szalai AJ, VanCott JL, McGhee JR, Volanakis JE, Benjamin WH Jr. 2001 "Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice". Infect Immun. 2000 Oct;68(10):5652-6. PubMed